One rainy Thursday afternoon near Taipei Arena, the Taipei Experience Center of RelaJet was fully booked with appointments from people with hearing loss eager to try hearing aids made with a voice separation engine For the hearing impaired, having affordable, lightweight, and effective noise-reducing hearing aids is truly a blessing 'We hope to help users in need to hear the world's wonders again' This empathetic expectation by RelaJet's founder and CEO Po-Ju Chen, who is also hearing impaired, illustrates his understanding of the needs of the hearing impaired He hopes that RelaJet's unique voice amplification hearing aid technology will benefit many more people Affordable hearing aids benefit many with hearing loss Founded in 2018 by Po-Ju Chen and his brother Yu-Ren Chen, RelaJet developed a multi-voice separation engine paired with Qualcomm's Bluetooth audio platform, drastically reducing the price of imported hearing aids, typically costing 80,000-100,000 NT dollars, to just under 10,000 NT dollars They aim to develop affordable goods with excellent noise-cancelling capabilities that wirelessly connect to smartphones In its first two years, the company primarily developed the multi-voice separation engine, which significantly improved the noise reduction quality Once equipped with Qualcomm Bluetooth earphone chips, the audio processing time is drastically short, at about 7 milliseconds to enhance main voice projection and reduce ambient noise, less than half the time required by traditional medical standard of 16 milliseconds for hearing aids, nearly 'zero-delay' 洞見未來科技推出平價助輔聽器，大大嘉惠聽損者 Yu-Ren Chen explains that the primary use of Qualcomm chips for edge computing, along with a streamlined algorithm, achieves extremely low latency and better noise reduction The hearing aids can cover 18 channels, whereas traditional hearing aids cover 4-48 channels In the future, RelaJet will progressively increase the number of channels According to statistics, there are 470 million people globally with hearing disabilities, with a 30 average device use rate in developed countries, with the highest in Western countries Taiwan has nearly 15 million people with disabling hearing loss, of which the middle-aged and elderly make up 30, yet the device use rate is only about 10, which is quite low Yu-Ren Chen further analyzes that the low device usage rate is due to two reasons firstly, the high average selling price of international big brands ranges from 80,000 to 200,000 NT dollars with a three-year usability period, which deters many due to the high cost and maintenance Secondly, in noisy environments, the noise is also amplified which does not necessarily ensure clarity for the users, and the sound parameters can't be adjusted in real-time, making it inconvenient to frequently visit stores for tuning Thirdly, most models cannot connect to smartphones, making it inconvenient for the hearing impaired to take phone calls Utilizing Qualcomm Bluetooth chips for rapid product development In light of this, Po-Ju Chen, formerly a semiconductor engineer at MediaTek, leads the technical development, while Yu-Ren Chen, with a legal background, manages the operations Their seamless collaboration, along with their team employing AI algorithms and chip integration, learns from thousands of hours of audio files in databases through neural networks and deep learning technologies to develop low-latency, high-noise-reduction voice amplification technologies for hearing aids In 2019, this sound processing technology was integrated into Qualcomm Bluetooth chips, winning first place in the Qualcomm Taiwan Startup Competition and becoming a partner in Qualcomm's Global Expansion Program, significantly boosting product development pace In 2021, they launched their own Otoadd series of hearingenhancement products in Taiwan, which received both market favor and positive reviews from many with hearing loss Based on different consumer needs, various product designs are available According to Yu-Ren Chen, the Otoadd wireless earphones with hearing enhancement functions, model N1, are entry-level neckband style priced at 9,500 NT per pair Users can wear the hearing aid while taking calls, and control noise reduction strength and volume through a mobile app They plan to develop accessories in the future tailored to the needs of older adults Besides being available for trials at experience centers in Taipei and Kaohsiung, this hearing aid is also sold through PChome, Taiwan Mobile's myfone, and Elder Age networks, among other channels Another model intended for individuals with mild to severe hearing loss is the Classic R hearing aid, which received the Japanese Good Design Award in 2021 Since its market debut last year, it has attracted those with congenital hearing loss, with users noting improved clarity in noisy environments and appreciating the convenience of Bluetooth connectivity for calls and watching videos This product is anticipated to be exported to international markets in the latter half of this year Additionally, a hearing aid product combining Bluetooth functionality, set to launch in June this year, is sized like typical Bluetooth earphones, targeting visually conscious consumers with hearing loss Its small size and attractive wireless earphone design allow for phone calls, and if approved by the Ministry of Health and Welfare, eligible users can apply for government subsidies RelaJet to expand into overseas markets, using the USA as a beachhead An interesting question arises due to the pandemic everyone must wear masks which impedes lip-reading How does this affect those with hearing loss Yu-Ren Chen indicates that this situation highlights RelaJet's advantages As each person with hearing loss has different levels of hearing ability, hearing aids can only augment to an appropriate volume, assisting users to hear about 60-70 content, with the remainder relying on lip reading and gestures During the pandemic, as everyone wears masks, masks also muffle sounds, but RelaJet's voice separation engine can correct and strengthen the separation, making it easier for those with hearing loss to recognize voices Besides the Taiwan market, RelaJet's next stage will be expanding into overseas markets, expecting to obtain ISO 13485 medical device quality management system certification and US medical device approval in 2022 They plan to enter the US market, either under their own brand or through OEM arrangements Apart from the Taiwan market, RelaJet will also enter the US market in the next phase for hearing aids「Translated content is generated by ChatGPT and is for reference only Translation date：2024-05-19」

In response to customer demand on a wide variety of products in small quantities in the manufacturing industry, there is an urgent need to find AI solutions from the cloud to terminals Claireye Intelligence provides a solution that integrates software and hardware - BailAI image inspection solution to assist traditional manufacturing industries in improving process efficiency and product quality, thereby achieving the initial goal of transformation After the government declared 2017 to be Taiwan's "First Year of AI," AI startups have sprung up in Taiwan Established in 2018, Claireye Intelligence targets smart manufacturing and provides a platform for AI image analysis and process optimization, using the power of deep learning to detect product defects and abnormalities in the assembly process It assists companies in building infrastructure from terminals to the cloud, which enables automated monitoring of factory production to improve process efficiency and quality Focusing on AI image inspection based on its familiarity with the production line quality control process Shirley Liu, founder and CEO of Claireye Intelligence, is a young entrepreneur She entered the manufacturing industry after graduating from college and held a quality control position in the plastic injection process of hard disk parts "She was already on the production line at the time, and is familiar with the production line process of production machinery" She later switched career paths to marketing and planning, and then worked as an AI product manager When the time came, Shirley Liu decided to start a business, focusing on AI image recognition in the manufacturing industry "The difficulty for enterprises is the lack of an AI development team Even if an enterprise has an AI team, development projects will take a lot of time, at least 6-12 months" said Shirley Liu, who is well versed in the market's pain points The problem that needs to be solved by platforms is to provide services that allow traditional manufacturing industries to build their own AI models without needing employees with a programming background, and to remotely assist production lines with troubleshooting and subsequent system maintenance, helping companies save development time and labor costs BailAI image inspection platform usage scenarios Facing the large number of competitors that provide AI image recognition in the market, what are the technical advantages of Claireye Intelligence Shirley Liu said that many companies currently have AOI equipment, but the bottleneck in the application of AOI is that it can only be used for defect inspection in fast production of large quantities, and parameters need to be adjusted after each inspection or production Based on her understanding of the industry, most SMEs are limited by their financial resources due to AOI equipment often costing over NT1 million, but they also want to use automated inspection This is where Claireye Intelligence comes in Shirley Liu went on to say that it is impossible for traditional manufacturing industries to maintain a technical team that includes AI engineers, data engineers, cloud architects, and terminal architects Claireye Intelligence specializes in software and hardware integration Enterprises can use the BailAI image inspection platform to easily solve inspection problems on the production line In other words, customers only need to provide images or samples for Claireye Intelligence to carry out model training, model deployment, and system integration, and they can easily use AI technology to optimize and monitor production line processes Participated in the AI New Talent Selection and achieved a recognition rate of over 90 in assembly behavioral image recognition For example, a certain connector manufacturer only has 1-2 AI engineers in its technical team The main problem that needs to be solved is that most operators are on the production line, while quality control and senior managers are not on site, and the company wants to understand the actual situation of the production line through remote monitoring Claireye Intelligence uses industrial cameras to capture production line images, and transmits AI image analysis to the remote end Supervisors and quality control personnel can observe if there are any errors in the production line assembly, such as whether the connectors and lines are connected properly, through the monitor Claireye Intelligence's AI image inspection operates on Microsoft's Azure cloud platform, and also utilizes terminal equipment, such as NVIDIA's edge computing equipment placed around the inspection station, to assist traditional manufacturing industries with improving production line efficiency and detecting problems early through an integrated solution from the cloud to terminals Claireye Intelligencersquos customers currently include aviation, electronic peripherals, connectors, and metal industries Assembly process solution for human behavior recognition in assembly lines achieves an accuracy of over 90 In order to demonstrate the depth of technology, Claireye Intelligence participated in the 2021 AI New Talents Selection of the Industrial Development Bureau, Ministry of Economic Affairs, and provided Lite-On Technology with the "assembly process solution for human behavior recognition in assembly lines" The solution determines effective working hours and ineffective working hours of operators on the production line through cameras and AI image recognition It recognizes hand posture and position through images to determine the operator's assembly behavior, achieving an accuracy of over 90 Shirley Liu added that the assembly process of electronic components is complex, mostly carried out manually, and cannot be replaced by robotic arms Claireye Intelligence used cameras to film the assembly process of operators at Lite-On's assembly station The algorithm is then trained and corrected based on the video, and the final trained model can directly determine whether there are any errors in the assembly process to improve the overall process Project development time is expected to be shortened to 1 month by using the BailAI image inspection platform Since its establishment more than three years ago, Claireye Intelligence has accumulated a considerable amount of project experience and hopes to commercialize the project experience Shirley Liu pointed out that the trial version of BailAI image inspection will be completed this year 2022 Customers can choose industrial cameras or video cameras based on the detail of the object being inspected It can even use X-rays to capture images, and then the images are automatically marked by the platform Claireye Intelligence will provide customers with AI application models suitable for the field Inferences can also be made in the cloud or terminals for launch in the manufacturing industry The metals industry, metal casings of industrial computers, connectors, electronic peripherals, and mechanical parts can all use the platform for defect detection and object identification Claireye Intelligence will continue to improve its technical capabilities, accumulate customer experience to complete commercialization, and also accelerate the implementation of AI inspection applications In the mid-term, it will build terminal and cloud infrastructure and shorten the development time of enterprise AI projects from 6-12 months to 1 month, reducing usage time and lowering the threshold for enterprises The long-term goal is to target the Southeast Asian market where Taiwanese businesses are gathered, expand software and hardware integrated AI solutions to overseas markets, and expand the scale of operations

Looking around the world and in Taiwan, the number of patients suffering from vertigo is increasing year by year When faced with vertigo testing, most people will choose to have it diagnosed by a doctor or hospitalized with neuromedical imaging tools such as MRI or CT for interpretation However, this may lead to misdiagnosis of vertigo, overdiagnosis of patients, waste of medical resources, etc, and cannot be effectively traced back The actual condition of the patient's dizziness In order to solve the long-term clinical pain point of vertigo, Neurobit has developed a smart wearable medical device - NeuroSpeed smart glasses and an AI assistance system It provides an AI smart solution for rapid screening of vertigo, assisting doctors in quickly screening more than 80 of brain diseases Efficient detection power with accuracy and sensitivity of over 90 Neuron Technology was founded in 2016 The co-founders include Yang Juncheng, Chen Weicheng, Huang Jinxun and Wang Jingfu The four of them were studying at the National Taiwan University Medical Engineering Institute and the Creative Entrepreneurship Program to jointly offer the "Biomedical Innovation and Commercialization" course Next, let’s embark on the entrepreneurial journey together The core team members of Neuron Technology are mainly composed of cross-field experts in medical engineering, information technology, neurology, patents, business, etc The common entrepreneurial concept is to continuously explore and explore unsolved pain points in medical clinical practice Seeing that patients were suffering from vertigo, Neuron Technology invented and independently developed an efficient and practical wearable smart medical device, NeuroSpeed Smart Glasses, which combines hardware AI-assisted decision-making system software to provide an AI smart solution for rapid dizziness screening Neuron Technology CEO Yang Juncheng said that the proportion of people in Taiwan and the world who suffer from vertigo is very high In Taiwan, as many as 3 of the people about 700,000 suffer from vertigo, while in the United States, about 1,000 people suffer from vertigo Tens of thousands of people go to see a doctor due to vertigo From the data, it can be seen that the vertigo medical care market is quite huge Regarding rapid screening for vertigo diagnosis in the clinic, current rapid screening tools in hospitals mainly use neurological examinations, and most of them are processed through questionnaire-type scales The diagnosis will rely too much on the patient's chief complaint and the doctor's experience judgment, and lacks quantitative indicators, resulting in Misdiagnosis of vertigo and loss of golden treatment time For patients with vertigo who are admitted to the emergency department, medical diagnosis in the past relied heavily on neuromedical imaging tools such as computed tomography CT or magnetic resonance imaging MRI After observation, it was found that the equipment was insufficient In the United States, the number of patients admitted to the emergency department Less than 3 of the population can receive immediate MRI diagnosis, and less than 50 can receive CT diagnosis However, excessive use of CT or MRI diagnosis may lead to overdiagnosis and treatment of patients, and even waste of medical resources In order to help vertigo patients accurately and efficiently screen and triage and reduce over-diagnosis in clinics and emergency rooms, NeuroSpeed Smart Glasses, a wearable smart medical device developed by Neuron Technology, is believed to have a great impact on the overall application of medical resources and patient diagnosis and treatment It is very helpful Yang Juncheng said that if it is not necessary to use MRI to track the diagnosis, this device can be used as a rapid screening test before the existing MRI neuroimaging tools and after the patient is admitted to the hospital, reducing over-diagnosis of patients NeuroSpeed's examination method is to quickly screen for nystagmus to identify patients with potential brain diseases The examination method of this technology is to observe the trembling state of the eyes and a series of eye movements when the subject is staring at a stationary object, so as to judge Brain risks for appropriate diagnosis and treatment NeuroSPeed smart glasses can crack brain and eye diseases, clinical trial sensitivity reaches 90 With the active research and development of Neuron Technology, two generations of NeuroSpeed smart glasses have been successfully launched The first generation NeuroSpeed mainly provides doctors with real-time observation of high-quality eye images and eye movement response-related examination data reference, and does not provide auxiliary diagnosis services The second generation of NeuroSpeed allows physicians to record, track, store and view relevant eye movement analysis and pupil area identification, thereby effectively diagnosing diseases of the central, meridian and peripheral nervous systems Because the second-generation NeuroSpeed product has the function of assisting doctors in analysis and diagnosis, it has been classified as a Class II medical device in the United States and must be certified by the US FDA before it can be sold externally At this stage, this product has completed pre-submission and will be submitted for review after the biocompatibility test is completed It is expected that the second generation NeuroSpeed will successfully obtain US FDA certification next year In terms of actual verification fields, NeuroSpeed has currently cooperated with New Taipei Shuanghe Hospital and Taichung Tzu Chi Hospital for clinical verification Its clinical results have confirmed the classification judgment of central nervous system diseases such as stroke and other vestibular system diseases With the addition of NeuroSpeed Smart glasses are designed to be lightweight and easy to carry, detect quickly and easily, and have the functional characteristics of automatic interpretation They can effectively assist doctors in quickly screening for potential brain disease risks in patients with vertigo Field verification with foreign medical centers mainly involves vertigo patients admitted to the emergency department Physicians can use NeuroSpeed smart devices to interpret the phenomenon of stroke diagnosis Currently, the accuracy of clinical trials in the above-mentioned cooperative hospitals reaches 80 and the sensitivity reaches 90 Neuron Technology develops smart wearable medical device NeuroSpeed smart glasses In addition to becoming the best smart medical assistant for doctors to quickly screen brain disease risks in the clinic and emergency department, NeuroSpeed smart glasses also assist doctors in the detection and assessment of strabismus risk They are jointly developed with the Tri-Service General Hospital through neuron technology The "Portable Strabismus and Abnormal Eye Movement Diagnosis System" is implemented in the Tri-Service General Hospital, providing doctors with a complete preoperative assessment of strabismus and postoperative tracking basis This excellent RD technology achievement was recognized by the 17th National Innovation Award-Clinical Innovation Award in 2020 We know that many diseases can cause congenital or acquired eye movement abnormalities, and even cause symptoms of strabismus or nystagmus Among them, as for strabismus, according to expert physician consultation surveys, the global prevalence of strabismus among school-age children is 2 5, while the prevalence of strabismus among school-age children in Taiwan is about 1 to 4 Yang Juncheng said that clinical diagnosis of the symptoms of these diseases is mainly divided into two categories deviation measurement of eye position and eye movement test It has been observed that there is currently a lack of objective quantitative methods for diagnosing eyeball position deviation, and eyeball deviation measuring instruments are used to check subjectively For Neuron Technology, the current NeuroSpeed instrument and strabismus and abnormal eye movement diagnosis system software can integrate objective and clear eyeball images, eye muscle function and eye deviation angle data as a rapid test that meets clinical diagnostic criteria Service, the data of these tests can be used as the basis for doctors’ complete preoperative assessment and postoperative tracking of strabismus Therefore, this system can provide objective and effective quantitative analysis, which can greatly reduce the medical risks of patients during surgery In terms of business model, Neuron Technology mainly cooperates with hospitals to sell research-based products It is believed that the company expects to have significant revenue performance after passing the FDA next year At present, Neuron Technology will use the country's first wearable smart medical device NeuroSpeed smart glasses and AI assistance system to provide software and hardware integrated solutions to assist doctors in quickly screening brain diseases and eye diseases, extending patients' golden treatment time and reducing social risks health care costs to create a triple win NeuroSpeed smart glasses assist doctors in quickly screening brain and eye diseases Looking at the world, the pioneer of smart medical equipment, a new paradigm of biomedical software and hardware system integration In the early days of Neuron Technology’s entrepreneurship, technology research and development and business expansion faced many challenges Yang Juncheng expressed his sentiments that since the NeuroSpeed product is the first medical smart glasses developed in China, both in terms of obtaining hardware raw materials and developing technical specifications, The challenges associated with building and integrating related systems are higher than those for consumer electronics Additionally, bringing together cross-disciplinary talent and integrating it into a core team is also an entrepreneurial challenge In terms of business development, although the company has accumulated clinical verification results and published related outputs, the establishment of market channels still requires continuous efforts to expand It is hoped that it can continue to rely on the assistance of legal persons such as the Capital Strategy Council to actively create more diversified market channels and connect potential Cooperating manufacturers In order to accelerate international expansion and market operation exchanges, the company will conduct a new round of fundraising planning at this stage to meet development Since its establishment, Neuron Technology has taken long-term development and stable profits as its operating goals Yang Juncheng said that in addition to focusing on existing professional fields, we also develop and apply value-added products through the company's software development and software development The accumulated RD energy of hard integration is expanded to other medical disciplines and fields Yang Juncheng hopes that Neuron Technology can become a pioneer in smart medical equipment, with research and development oriented to meet the needs of users and patients, and also hopes to become a model for the integration of biomedical software and hardware systems For the medium and long-term layout, the company will promote industry-university exchanges and cultivate biomedical talents integrate upstream and downstream industry resources to create smart medical solutions and platforms and actively explore foreign sales markets such as the United States and Europe as a basis for sustainable development of the company Vision 「Translated content is generated by ChatGPT and is for reference only Translation date：2024-05-19」